Drug target review.

中文名称：审查药物目标。

ISSN：2059-1349
出版周期：Quarterly

发文量：457

期刊论文

热门论文

年度选择

更多>>

全选（0）

1.Spatial biology is the next life science revolution

机译：Spatial biology is the next life science revolution
- 作者：Richard Goodwin
- 期刊名称：《Drug target review.》 | 2022年第2期
2.A reproducible and scalable Huntington's disease human cell model

机译：A reproducible and scalable Huntington's disease human cell model
- 期刊名称：《Drug target review.》 | 2022年第2期
3.A multi-step analysis including GCI reveals novel insight into LP5 translocation

机译：A multi-step analysis including GCI reveals novel insight into LP5 translocation
- 作者：Michael Hennig
- 期刊名称：《Drug target review.》 | 2022年第2期
4.Targeted protein degradation: turning undruggable targets into druggable targets

机译：Targeted protein degradation: turning undruggable targets into druggable targets
- 作者：Masahiko Hayakawa;Yoshitsugu Shitaka
- 期刊名称：《Drug target review.》 | 2023年第1期
5.Addressing the grand challenge of global access to vaccines

机译：Addressing the grand challenge of global access to vaccines
- 作者：Tracy Saveria;James Roberts;Brian Finrow
- 期刊名称：《Drug target review.》 | 2023年第1期
6.An innovative targeted pathway to treat rare autoantibody diseases

机译：An innovative targeted pathway to treat rare autoantibody diseases
- 作者：Katie Abouzahr
- 期刊名称：《Drug target review.》 | 2023年第1期
7.Biomarkers as key tools for advancing Alzheimer's drug development

机译：Biomarkers as key tools for advancing Alzheimer's drug development
- 作者：Steve Hoffmann;Alessio Tavaglia
- 期刊名称：《Drug target review.》 | 2023年第2期
8.De-risking drugs in multiplex assays before progressing to clinical trials

机译：De-risking drugs in multiplex assays before progressing to clinical trials
- 作者：Sheraz Gul
- 期刊名称：《Drug target review.》 | 2023年第1期
9.Unleashing the power of single-cell technologies and AI/ML for cell-centric drug discovery

机译：Unleashing the power of single-cell technologies and AI/ML for cell-centric drug discovery
- 作者：Fabrice Chouraqui;Taylor Mixides
- 期刊名称：《Drug target review.》 | 2023年第2期
10.Human disease genetics:connecting variants to function

机译：Human disease genetics:connecting variants to function
- 作者：Pushpanathan Muthuirulan
- 期刊名称：《Drug target review.》 | 2023年第1期
11.Next-generation CAR T cells

机译：Next-generation CAR T cells
- 作者：John Maher
- 期刊名称：《Drug target review.》 | 2023年第2期
12.Raman Imaging: adding value to formulation development

机译：Raman Imaging: adding value to formulation development
- 作者：Adam Holl
- 期刊名称：《Drug target review.》 | 2023年第2期
13.How to Improve Glycoform and Glycopeptide Coverage for Mucin Preparations

机译：How to Improve Glycoform and Glycopeptide Coverage for Mucin Preparations
- 期刊名称：《Drug target review.》 | 2023年第2期
14.Enhancing drug discovery and development with cutting-edge microplate readers

机译：Enhancing drug discovery and development with cutting-edge microplate readers
- 作者：Marina Junqueira Santiago
- 期刊名称：《Drug target review.》 | 2023年第2期
15.Shared neoantigens: their potential and drawbacks as off-the-shelf therapeutic targets

机译：Shared neoantigens: their potential and drawbacks as off-the-shelf therapeutic targets
- 作者：Lien Lybaert;Bruno Fant
- 期刊名称：《Drug target review.》 | 2023年第2期
16.Providing new hope for rare disease using non-viral gene therapy

机译：Providing new hope for rare disease using non-viral gene therapy
- 作者：Brent Warner
- 期刊名称：《Drug target review.》 | 2022年第2期
17.Anticipating results in CAR T-celI therapy

机译：Anticipating results in CAR T-celI therapy
- 作者：Felipe Prosper;Juan Jose Lasarte;Paula Rodriguez MarquezMikel HernaezJuan Roberto Rodriguez Madoz
- 期刊名称：《Drug target review.》 | 2023年第2期
18.From cells to simulations:exploring alternatives to animal testing in drug discovery

机译：From cells to simulations:exploring alternatives to animal testing in drug discovery
- 作者：Ria Kakkad
- 期刊名称：《Drug target review.》 | 2023年第1期
19.Novel screening tools for TMEM175 drug discovery

机译：Novel screening tools for TMEM175 drug discovery
- 期刊名称：《Drug target review.》 | 2023年第2期
20.The most important drug discovery event of the year?

机译：The most important drug discovery event of the year?
- 期刊名称：《Drug target review.》 | 2023年第2期
21.SARS-CoV-2 spike protein dihedral angle oscillations reveal favoured rotation frequencies

机译：SARS-CoV-2 spike protein dihedral angle oscillations reveal favoured rotation frequencies
- 作者：Oscar Bastidas;Zoran Sevarac
- 期刊名称：《Drug target review.》 | 2023年第1期
22.Exploring the frontiers of drug discovery: Championing the contributions of female scientists

机译：Exploring the frontiers of drug discovery: Championing the contributions of female scientists
- 作者：Nic Losardo;Ria Kakkad;Izzy Wood
- 期刊名称：《Drug target review.》 | 2023年第1期
23.More than just a micriscope: How advanced imaging modalities can take your pharmaceutical research to the next level

机译：More than just a micriscope: How advanced imaging modalities can take your pharmaceutical research to the next level
- 作者：Laurent A. Bentolila;Haley Marks;Brian Jeong
- 期刊名称：《Drug target review.》 | 2023年第2期
24.Unveiling cutting-edge advances in drug discovery

机译：Unveiling cutting-edge advances in drug discovery
- 作者：Taylor Mixides
- 期刊名称：《Drug target review.》 | 2023年第2期
25.Sustaining momentum in iPSC-derived allogeneic cell therapies

机译：Sustaining momentum in iPSC-derived allogeneic cell therapies
- 作者：Stefan Braam;Andy Holt
- 期刊名称：《Drug target review.》 | 2023年第1期
26.High-throughput detection of degraded polysorbate in biological formulations with FMM

机译：High-throughput detection of degraded polysorbate in biological formulations with FMM
- 作者：Bernardo Cordovez;Steven Le
- 期刊名称：《Drug target review.》 | 2023年第1期
27.Advancing gene editing to redefine genetic disease treatment

机译：Advancing gene editing to redefine genetic disease treatment
- 作者：Brent Warner
- 期刊名称：《Drug target review.》 | 2023年第2期
28.The role of CRISPR in microbiome engineering breakthroughs

机译：The role of CRISPR in microbiome engineering breakthroughs
- 作者：Richard Fox;Jakob Krause Haaber
- 期刊名称：《Drug target review.》 | 2023年第2期
29.How diagnostics tabs safeguard patients

机译：How diagnostics tabs safeguard patients
- 作者：Kjetil Kraemer
- 期刊名称：《Drug target review.》 | 2023年第1期
30.T cells' vital role in boosting immune responses

机译：T cells' vital role in boosting immune responses
- 作者：Izzy Wood
- 期刊名称：《Drug target review.》 | 2023年第2期
31.Further, faster, together: the key to cancer drug discovery is cross-sector collaboration

机译：Further, faster, together: the key to cancer drug discovery is cross-sector collaboration
- 作者：Hamish Ryder
- 期刊名称：《Drug target review.》 | 2023年第2期
32.Overcoming challenges in metastatic breast cancer

机译：Overcoming challenges in metastatic breast cancer
- 作者：Volkmar Muller
- 期刊名称：《Drug target review.》 | 2023年第2期
33.Accurate quantification of viral vectors without a standard curve

机译：Accurate quantification of viral vectors without a standard curve
- 作者：Daniel Heinz Lofgren
- 期刊名称：《Drug target review.》 | 2023年第2期
34.The remit of expertise puttingnanomaterials to work

机译：The remit of expertise puttingnanomaterials to work
- 作者：Tom Darlington
- 期刊名称：《Drug target review.》 | 2023年第1期
35.Advancing directed protein evolution technoligy

机译：Advancing directed protein evolution technoligy
- 作者：Victoria Goldenshtein
- 期刊名称：《Drug target review.》 | 2023年第2期
36.Why automation is outpacing traditional methods for single-cell cloning

机译：Why automation is outpacing traditional methods for single-cell cloning
- 期刊名称：《Drug target review.》 | 2023年第1期
37.Epigenetic editing: the next generation of genetic medicine

机译：Epigenetic editing: the next generation of genetic medicine
- 作者：Blythe Sather
- 期刊名称：《Drug target review.》 | 2023年第1期
38.The evolution and promise of gene therapies

机译：The evolution and promise of gene therapies
- 作者：David Baram
- 期刊名称：《Drug target review.》 | 2023年第2期
39.Assay performance andthe Z'-factor in HTS

机译：Assay performance andthe Z'-factor in HTS
- 作者：Matthew Lloyd
- 期刊名称：《Drug target review.》 | 2023年第1期